Mechanism underlying thrombus formation in cerebral infarction

Clinical Neurology

Volumn 49, Issue 11, 2009, Pages 798-800

  Kitagawa, Kazuo ^a   Sakoda, Saburo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti platelet drug; Anticoagulation; Inflammation; Plaque vulnerability; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CILOSTAZOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT; FIBRIN;

ANTICOAGULANT THERAPY; ARTERY ENDOTHELIUM; ARTERY INJURY; ARTERY THROMBOSIS; ATHEROSCLEROTIC PLAQUE; BLOOD COMPONENT; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOGENIC EMBOLISM; CONFERENCE PAPER; EMBOLISM; ENDOTHELIUM INJURY; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; RECURRENT DISEASE; STROKE; THROMBOCYTE AGGREGATION; VENOUS STASIS; CAROTID ARTERY OBSTRUCTION; HUMAN; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOSIS;

ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD PLATELETS; CAROTID STENOSIS; CEREBRAL INFARCTION; FIBRIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PLATELET AGGREGATION INHIBITORS; RECURRENCE; THROMBOSIS;

EID: 77956205021     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.49.798     Document Type: Conference Paper

References (10)

1. Gage BF, van Walraven C, Pearce L, et al: Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004; 110: 2287-2292 (Pubitemid 39407328)
2. Mant J, Hobbs FD, Fletcher K, et al: Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503 (Pubitemid 47212371)
3. Connolly S, Pogue J, Hart E, et al: Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006; 367: 1903-1912
4. Sato H, Ishikawa K, Kitabatake A, et al: Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke 2006; 37: 447-451 (Pubitemid 43732003)
5. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86
6. Diener HC, Bogousslavsky J, Brass LM, et al: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients ( MATCH ): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331-337
7. Mohr JP, Thompson JL, Lazar RM, et al: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345: 1444-1451
8. Halkes PH, van Gijn J, Kappelle LJ, et al: Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. Lancet Neurol 2007; 6: 115-124
9. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al: Comparison ofwarfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305-1316
10. Yamagami H, Kitagawa K, Nagai Y, et al: Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques. Stroke 2004; 35: 677-681 (Pubitemid 38280840)